Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. LOGSX: which is better?

Bottom line

FHLC vs LOGSX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 31% of their top holdings (by weight) are shared.

But FHLC is far broader, holding 337 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

FHLC is cheaper at 0.084% vs 1.04% — a difference of $96 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs +7.2% for FHLC (reporting dates differ).

Updated Nov 19, 2026

FHLC vs LOGSX side by side

FHLCLOGSX
TypeETFMutual fund
Fund familyFidelityOak Associates
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%1.04%
Annual cost per $10k$8.4$104
10-yr cost on $10k (prospectus)$108$1,271
Max front loadNone—
12b-1 fee0%—
1-yr return+2.6%+19.6%
5-yr return (annualized)+7.2%+8.1%
10-yr return (annualized)+8.8%+7.3%
Best quarter+16.4%+13.4%
Worst quarter−13.1%−13.1%
Net assets (fund)$3.3B$56.1M
Number of holdings33728
Portfolio turnover3%24%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCLOGSXDifference
2024+2.6%+0.2%+2.4%
2023+2.5%+1.2%+1.3%
2022−5.5%+3.7%−9.2%
2021+20.4%+17.5%+2.9%
2020+18.1%+6.0%+12.2%
2019+21.9%+19.0%+3.0%
2018+5.5%−4.0%+9.5%
2017+23.3%+13.4%+9.9%
2016−3.3%−0.4%−3.0%

Source: Fund prospectus bar charts

Holdings overlap

13 of FHLC's top 25 holdings also appear in LOGSX's top 25.

Shared top holdings
HoldingFHLCLOGSX
Eli Lilly & Co13.35%1.99%
Johnson & Johnson8.93%3.77%
Merck & Co Inc4.66%3.16%
Amgen Inc3.00%4.86%
Gilead Sciences Inc2.34%3.50%
Bristol-Myers Squibb Co1.93%4.02%
Intuitive Surgical Inc1.82%2.99%
Vertex Pharmaceuticals Inc1.76%3.26%
McKesson Corp1.52%4.53%
Regeneron Pharmaceuticals Inc1.15%4.43%
Cigna Group/The1.06%3.46%
Cencora Inc0.83%4.46%
Cardinal Health Inc0.78%5.86%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

FAQ

What is the difference between FHLC and LOGSX?
FHLC (Fidelity MSCI Health Care Index ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 31% of their top holdings (by weight) are shared. But FHLC is far broader, holding 337 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, FHLC or LOGSX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and LOGSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.